Keyphrases
Sternal Biopsy
50%
Diffuse Idiopathic Skeletal Hyperostosis
50%
Translational Oncology
50%
Magnetic Resonance Findings
50%
Hospital Experience
50%
Healthcare Utilization
50%
University Hospital
50%
United States Medical Licensing Examination
50%
Race-ethnicity
50%
Associated Morbidity
50%
MEIS1-NCOA2
50%
Tumor-induced Osteomalacia
50%
Phosphaturic Mesenchymal Tumor
50%
Factor Inhibitors
50%
Pexidartinib
50%
Unintended Consequences
50%
Tenosynovial Giant Cell Tumor
50%
Diffuse Type
50%
CSF-1
50%
Monomelic Amyotrophy
50%
Core Exam
50%
Regional Community
50%
Body CT
50%
Biopsy Planning
33%
Size-specific Dose Estimate
30%
Core Examination
28%
Medical School Rank
25%
Molecular Materials
25%
Numerics
25%
African American
25%
Discrete Choice Experiment
25%
Real-time Process
25%
Preference Weights
25%
Hispanic
25%
Pediatric CT
20%
Magnetic Resonance Imaging
18%
Implant Interface
16%
Bone Hypertrophy
16%
Bone Neoplasms
16%
Musculoskeletal (MSK) Biopsies
16%
Underrepresented in Medicine
12%
Clerkship
12%
Response Rate
12%
Bone Tumor Biopsy
12%
Technical Imaging
12%
Attribute Level
12%
Radiology Department
12%
Residency
12%
Osseous Lesions
12%
Conditional Logistic Regression
12%
Medicine and Dentistry
Castration Resistant Prostate Cancer
100%
Bone Biopsy
100%
Biopsy
93%
Neoplasm
62%
Radiology
53%
Clinical Decision Making
50%
Predictive Factor
50%
Pexidartinib
50%
Ankylosing Hyperostosis
50%
Pediatrics
50%
Translational Oncology
50%
Spindle Cell
50%
Rhabdomyosarcoma
50%
Osseointegration
50%
Diagnosis
50%
Oncogenic Osteomalacia
50%
Immunohistochemistry
37%
Implant
30%
Sclerosis
25%
Gene Fusion
25%
Alkaline Phosphatase
25%
Metastatic Carcinoma
20%
Bone Cancer
18%
Disease
14%
Soft Tissue Tumor
12%
Tumor Cell
12%
Prostate Cancer
12%
Bone Tissue
12%
Tumor Biopsy
12%
RNA Sequence
12%
Drug Therapy
10%
Epileptic Absence
10%
Clinician
10%
Sensitivity and Specificity
10%
Intramedullary Nailing
10%
Radiography
10%
Pathologic Fracture
10%
Recurrent Disease
8%
Disease Course
8%
Backache
7%
Spine Surgery
7%
Volume CT
7%
Orthopedics
6%
Laboratory Test
6%
Malignant Neoplasm
6%
Image Guided Biopsy
6%
Health Care Cost
6%
Therapy Delay
6%
Anticarcinogen
6%
Clinical Trial
6%
